Literatur
Green RM, Flamm S (2002) AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 123: 1367–1384
Metcalf JV, Bhopal RS, Gray J, Howel D, James OF (1997) Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol 26: 830–836
Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353: 1261–1273
Heathcote EJ (2000) Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31: 1005–1013 AASLD Guidelines: www.aasld.org/eweb/docs/biliarycirrhosis.pdf
Paumgartner G, Beuers U (2004) Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 8: 67–81
Lee YM, Kaplan MM, LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH, Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S, Angulo P, Lindor KD, Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF (1995) Primary sclerosing cholangitis. N Engl J Med 332: 924–933
LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH (2006) Primary sclerosing cholangitis: summary of a workshop. Hepatology 44: 746–764
Zimmermann HJ (1999) Drug-induced liver disease. In: Schiff ER, Sorrell MF, Maddrey WC (eds) Schiff's diseases of the liver, 8th edn. Lippincott, Philadelphia, pp 973–1064
Trauner M, Graziadei IW (1999) Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Aliment Pharmacol Ther 13: 979–996
Lammert F, Marschall HU, Glantz A, Matern S (2000) Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 33: 1012–1021
Bacq Y, Myara A, Brechot MC, Hamon C, Studer E, Trivin F, Metman EH (1995) Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. J Hepatol 22: 66–70
Chand N, Sanyal AJ (2007) Sepsis-induced cholestasis. Hepatology 45: 230–241
Trauner M, Fickert P, Stauber RE (2003) Sepsis und Leber. Intensivmed 40: 475–483
Schmid M, Hefti ML, Gattiker R, Kistler HJ, Senning A (1965) Benign postoperative intrahepatic cholestasis. N Engl J Med 272: 545–550
Engler S, Elsing C, Flechtenmacher C, Theilmann L, Stremmel W, Stiehl A (2003) Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 52: 688–693
Glasova H, Beuers U (2002) Extrahepatic manifestations of cholestasis. J Gastroenterol Hepatol 17: 938–948
Bergasa NV (2005) The pruritus of cholestasis. J Hepatol 43: 1078–1088
Sen S, Williams R, Jalan R (2005) Emerging indications for albumin dialysis. Am J Gastroenterol 100: 468–475
Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ (2007) Sertraline as a first-line treatment for cholestatic pruritus. Hepatology 45: 666–674
Leslie WD, Bernstein CN, Leboff MS (2003) AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125: 941–966
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zollner, G., Fickert, P. & Trauner, M. Cholestase. wkw education 2, 125–140 (2007). https://doi.org/10.1007/s11812-007-0029-6
Issue Date:
DOI: https://doi.org/10.1007/s11812-007-0029-6